These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2005717)
1. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining. Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T J Urol; 1991 Apr; 145(4):846-9. PubMed ID: 2005717 [TBL] [Abstract][Full Text] [Related]
2. Cell proliferation of human bladder tumors. Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T J Urol; 1989 Oct; 142(4):1113-6. PubMed ID: 2795741 [TBL] [Abstract][Full Text] [Related]
3. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Cher ML; Chew K; Rosenau W; Carroll PR Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002 [TBL] [Abstract][Full Text] [Related]
4. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Waldman FM; Carroll PR; Cohen MB; Kerschmann R; Chew K; Mayall BH Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979 [TBL] [Abstract][Full Text] [Related]
5. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder. Cohen MB; Waldman FM; Carroll PR; Kerschmann R; Chew K; Mayall BH Hum Pathol; 1993 Jul; 24(7):772-8. PubMed ID: 8100555 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Goodson WH; Moore DH; Ljung BM; Chew K; Mayall B; Smith HS; Waldman FM Breast Cancer Res Treat; 2000 Jan; 59(2):113-23. PubMed ID: 10817346 [TBL] [Abstract][Full Text] [Related]
7. Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry. Le Pessot F; Michel P; Paresy M; Lemoine F; Hellot MF; Paillot B; Scotte M; Peillon C; Hemet J Pathol Res Pract; 2001; 197(6):411-8. PubMed ID: 11432668 [TBL] [Abstract][Full Text] [Related]
8. Growth fraction of human bladder tumors. Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T Urol Res; 1991; 19(4):215-8. PubMed ID: 1926655 [TBL] [Abstract][Full Text] [Related]
9. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis. Wu YF; Xu HM; Chen JQ Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378 [TBL] [Abstract][Full Text] [Related]
10. [S-phase cells of human bladder tumors by in vivo bromodeoxyuridine labeling]. Ohyama C; Nakazumi H; Satoh M; Yoshikawa K; Hoshi S; Orikasa S; Hayashi T; Mituno S; Murakami F; Kurosu S Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):524-31. PubMed ID: 2374324 [TBL] [Abstract][Full Text] [Related]
11. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702 [TBL] [Abstract][Full Text] [Related]
12. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors. Sasaki K; Matsumura K; Tsuji T; Shinozaki F; Takahashi M Cancer; 1988 Sep; 62(5):989-93. PubMed ID: 3409179 [TBL] [Abstract][Full Text] [Related]
13. The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer. Goodson WH; Moore DH; Ljung BM; Chew K; Florendo C; Mayall B; Smith HS; Waldman FM Breast Cancer Res Treat; 1998 May; 49(2):155-64. PubMed ID: 9696398 [TBL] [Abstract][Full Text] [Related]
14. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Onda K; Davis RL; Wilson CB; Hoshino T Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951 [TBL] [Abstract][Full Text] [Related]
15. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67. Morimura T; Kitz K; Budka H Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990 [TBL] [Abstract][Full Text] [Related]
16. The kinetics of cellular proliferation in rat urinary bladder treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T J Urol; 1990 Dec; 144(6):1493-6. PubMed ID: 2231954 [TBL] [Abstract][Full Text] [Related]
17. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours. Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743 [TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma]. Yuge F; Hirakata H; Igarashi H; Kodama M; Kawata N; Takimoto Y Hinyokika Kiyo; 1999 Jul; 45(7):453-6. PubMed ID: 10466059 [TBL] [Abstract][Full Text] [Related]
19. Bromodeoxyuridine labelling of transitional cell carcinoma of the bladder--an index of recurrence? Popert RJ; Joyce AD; Thomas DJ; Walmsley BH; Coptcoat MJ Br J Urol; 1993 Mar; 71(3):279-83. PubMed ID: 8477314 [TBL] [Abstract][Full Text] [Related]
20. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations. Sahin AA; Ro JY; el-Naggar AK; Wilson PL; Teague K; Blick M; Ayala AG Am J Clin Pathol; 1991 Oct; 96(4):512-9. PubMed ID: 1716414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]